High Flow Nasal Cannula Market size is anticipated to reach USD 17 Billion by the end of 2033, growing at a CAGR of 12% during the forecast period, i.e., 2023-2033. In the year 2022, the industry size of high flow nasal cannula was USD 9 Billion. The growth of the market is primarily attributed to the radically increasing cases of asthma along with chronic obstructive pulmonary diseases across the globe. As per the World Health Organization, globally, asthma is expected to have killed 455 000 people in 2019 and impacted 262 million people in the same year. Increasing air pollution is caused by the presence of particulate matter and ozone, and an increasing number of indoor air pollutants, which include tobacco smoke, dust mites, cockroaches, mold & pesticides. The pollution caused by fossil fuel combustion, the growing number of industries, transportation, and the rising use of chemicals across the world is estimated to propel the growth of the market.
The nasal cannula is used in cases where people are not able to breathe or get sufficient oxygen for the proper functioning of the body. This is a common phenomenon among patients who are suffering from asthma, COPD, or any other respiratory illness. In addition to this, the high-flow nasal cannula market is estimated to grow on the basis of the rising prevalence of asthma and respiratory tract illnesses among children across the world. Also, asthma is the most common chronic condition affecting children as per the reports. As per the estimations, about 5.1 million asthmatic children are under the age of 18. Moreover, about, 11 Americans die from asthma every day, and asthma-related deaths reached to 4,145 in the year 2020. Besides this, the launch of novel advanced products by the key manufacturers is another major factor that is fueling the growth of the market over the projected period.
Growth Drivers
Challenges
|
Base Year |
2022 |
|
Forecast Year |
2023-2033 |
|
CAGR |
~12% |
|
Base Year Market Size (2022) |
~ USD 9 Billion |
|
Forecast Year Market Size (2033) |
~ USD 17 Billion |
|
Regional Scope |
|
Application (Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease, Acute Heart failure)
The global high-flow nasal cannula market is segmented and analyzed for demand and supply by application into acute respiratory failure, chronic obstructive pulmonary disease (COPD), acute heart failure, and others. Among these segments, the COPD segment is estimated to garner the largest market share as per the market analysis. COPD is a common pulmonary disease that affects the lungs of the patient. Furthermore, the increasing number of COPD cases is owing to the growing occupational inhalation of chemicals or dust. In addition, long-term exposure to tobacco smoke, indoor air pollution from allergens including animal fur, plant pollen, cooking smoke from cow dung or wood, the presence of respiratory infections, and any genetic deficiency are estimated to cause COPD. Across the world, over 3.23 million people died from COPD in 2019, as per the World Health Organization. The treatment with the high flow oxygen via nasal cannula helps to reduce respiratory rate and supports COPD patients with acute hypercapnic respiratory illness. It improves gas exchange in the blood to purify deoxygenated blood. This increase in demand for high flow nasal cannula application in COPD patients is anticipated to surge the segment’s growth in the market.
End-user (Hospitals & Clinics, Ambulatory Care Centers, Long-Term Care Centers)
The global high-flow nasal cannula market is also segmented and analyzed for demand and supply by end-user into hospitals and clinics, ambulatory care centers, long-term care centers, and others. Out of these, the hospitals & clinics segment is estimated to gain the largest market share by the end of 2033 on the back of the requirement for high flow nasal cannulas in hospitals and clinics, which is based on usage for a predetermined number of patients. Moreover, the number of hospitals and surgeries is growing, thus increasing the usage of the nasal cannula in the hospital is further predicted to boost the segment’s growth in the market. Further, approximately 40 to 50 million major surgeries are performed in the USA every year, and about 20 million in Europe, out of 310 million surgeries across the world.
Our in-depth analysis of the global market includes the following segments:
|
By Type |
|
|
By Application |
|
|
By End-User |
|
APAC Market Statistics
The Asia Pacific high-flow nasal cannula market is projected to hold the largest market share by the end of 2033. The growth of the market can be attributed majorly to the growing geriatric and pediatric population, along with the increasing prevalence of asthma in the region. By 2050, one in four individuals in the region of Asia Pacific is estimated to get older than 60, and the incidence of asthma in the elderly population is about 1.3 to 15.3% compared to 5 percent of adults in the region, as per the reports. Moreover, with the rising cases of chronic respiratory diseases, there is also a surge in the number of surgeries conducted in the region every year. Along with this, the growing healthcare infrastructure, and improving healthcare facilities in the region are estimated to drive market growth in the region during the forecast period. The increasing urbanization from growing industries releases harmful gases and chemicals into the environment. In addition, the increasing automobile industry is also estimated to rise air pollution owing to elevating vehicles on the road.
ResMed Corp. As per an abstract submitted at the European Respiratory Society Congress organized by ResMed, more than 480 million people are suffering from COPD worldwide.
Eakin Healthcare Group – Eakin Healthcare Group acquired Coleraine-based Armstrong Medical, which specialized in respiratory care products, and its headquarters is located at Northern Ireland.
Author Credits: Radhika Gupta, Shivam Bhutani
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?